Single-cell transcriptomics dissects epithelial heterogeneity in HPV + cervical adenocarcinoma.
Cong WangLei LiFuhao WangXia LiJujie SunXiaohui LiTianyu LeiQingyu HuangGuangyu ZhangHongqing WangDapeng LiJue JiaChunyan LiFeng GengJinbo YueChao LiuPublished in: Journal of medical virology (2023)
The intra- and intertumoral heterogeneity of epithelial cells in human papillomavirus (HPV + ) cervical adenocarcinoma (CEAD) remains largely unknown. To investigate this issue, we performed single-cell RNA sequencing on 19 229 epithelial cells sorted from three tumor samples of three patients with HPV + CEAD. Six epithelial subclusters (Epi1-Epi6) were identified that showed distinct gene expression. Among these, Epi1 and Epi4 had apparent tumor hallmarks and metabolic activities. Epi1 was highly enriched in hallmarks of hypoxia, IL2/STAT5 signaling, retinol metabolism, glycolysis, and arachidonic acid metabolism, while Epi4 was highly enriched in hallmarks of G2M checkpoint, E2F targets, DNA repair, PI3K/AKT/MTOR signaling, glycolysis, fatty acid degradation, TCA cycle, and glutathione metabolism. We also investigated intertumoral epithelial heterogeneity and found that Patient 1 was highly enriched for KRAS signaling and angiogenesis, while Patient 2 was highly enriched for epithelial-mesenchymal transition and TGF-β signaling, and Patient 3 was highly enriched for hypoxia, DNA repair, G2M checkpoint, and E2F targets. Using single-cell RNA sequencing, we revealed the intra- and intertumoral heterogeneity of epithelial cells in HPV + CEAD, providing insights into the importance of personalized treatment for patients with HPV + CEAD.
Keyphrases
- single cell
- dna repair
- rna seq
- dna damage
- high grade
- high throughput
- gene expression
- epithelial mesenchymal transition
- case report
- endothelial cells
- fatty acid
- cervical cancer screening
- dna damage response
- squamous cell carcinoma
- transforming growth factor
- cell cycle
- cell proliferation
- computed tomography
- oxidative stress
- dna methylation
- signaling pathway
- vascular endothelial growth factor
- magnetic resonance
- combination therapy
- contrast enhanced